Brief: Hillstream Biopharma On May 17 Concluded That Co's Accounting For Recording Certain Financed Insurance Policies Was Considered Incorrect
May 22 (Reuters) - Hillstream BioPharma Inc HILS.O :
* HILLSTREAM BIOPHARMA - ON MAY 17, CONCLUDED THAT CO'S
ACCOUNTING
FOR RECORDING CERTAIN FINANCED INSURANCE POLICIES WAS CONSIDERED
INCORRECT
* HILLSTREAM BIOPHARMA - PREVIOUSLY ISSUED AUDITED
FINANCIAL
STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2022 SHOULD NO LONGER
BE RELIED UPON
* HILLSTREAM BIOPHARMA - EARLIER GIVEN, UNAUDITED FINANCIAL
STATEMENTS FOR QTRS ENDED IN 2022 MARCH 31, JUNE 30, SEPT 30,
CAN NO LONGER BE RELIED UPON
Source text: [ID:http://ml6.in/eLQcg]
Further company coverage: HILS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Canton Strategic Holdings
See all newsBrief: Canton Strategic Holdings, Inc. Releases Second Quarter 2026 Financial And Operational Results
Canton Strategic reports first operating revenue in Q2
Brief: Three New Directors Elected To The Board Of Canton Strategic Holdings, Inc.
Brief: Canton Strategic Holdings, Inc. Expected To Be Included In Russell 3000® And Russell 2000®
Brief: Canton Strategic Authorizes Share Repurchase Program For Up To $50 Million In Common Stock